Tofisopam (Emandaxin, Grandaxin, Sériel) is an anxiolytic that is marketed in several European countries. Chemically, it is a 2,3-benzodiazepine. Unlike...
9 KB (733 words) - 06:09, 9 February 2024
Opipramol Oxaflozane‡ Phenaglycodol Phenibut Picamilon Selank Tiagabine Tofisopam Validolum #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never...
54 KB (4,803 words) - 20:56, 22 June 2024
Opipramol Oxaflozane‡ Phenaglycodol Phenibut Picamilon Selank Tiagabine Tofisopam Validolum #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never...
67 KB (6,416 words) - 12:00, 25 July 2024
Opipramol Oxaflozane‡ Phenaglycodol Phenibut Picamilon Selank Tiagabine Tofisopam Validolum #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never...
35 KB (2,855 words) - 04:10, 1 July 2024
Opipramol Oxaflozane‡ Phenaglycodol Phenibut Picamilon Selank Tiagabine Tofisopam Validolum #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never...
91 KB (8,959 words) - 22:04, 29 July 2024
Opipramol Oxaflozane‡ Phenaglycodol Phenibut Picamilon Selank Tiagabine Tofisopam Validolum #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never...
159 KB (16,654 words) - 05:27, 30 July 2024
Opipramol Oxaflozane‡ Phenaglycodol Phenibut Picamilon Selank Tiagabine Tofisopam Validolum #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never...
101 KB (10,398 words) - 03:34, 30 July 2024
Opipramol Oxaflozane‡ Phenaglycodol Phenibut Picamilon Selank Tiagabine Tofisopam Validolum #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never...
99 KB (8,544 words) - 12:04, 29 July 2024
PF-04447943 Paraxanthine PDE10 Balipodect Mardepodect Papaverine TC-E 5005 Tofisopam PDE11 BC11-38 Non-selective Aminophylline Caffeine Choline theophyllinate...
82 KB (7,334 words) - 04:37, 1 July 2024
Opipramol Oxaflozane‡ Phenaglycodol Phenibut Picamilon Selank Tiagabine Tofisopam Validolum #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never...
127 KB (13,891 words) - 15:33, 19 July 2024